Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.

The prognostic value of Ki-67 immunohistochemical labelling was evaluated in 327 operable primary carcinomas of the breast. The follow-up time was up to 4 years (mean 2.7 years). The disease-free survival in Ki-67 positive patients was shorter than in Ki-67 negative patients (P < 0.005). By combi...

Descripción completa

Detalles Bibliográficos
Autores principales: Railo, M., Nordling, S., von Boguslawsky, K., Leivonen, M., Kyllönen, L., von Smitten, K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1993
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968381/
https://www.ncbi.nlm.nih.gov/pubmed/8394732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968381/
https://www.ncbi.nlm.nih.gov/pubmed/8394732

Ejemplares similares